For women who experience trouble becoming pregnant naturally, the option of in vitro fertilization (IVF) is available, but may not be the best fit for all. According to Fox Health, an experimental fertility treatment known as in vitro maturation (IVM) could provide results with a shorter hormone course than the usual method. When undergoing the “priming phase” of IVM, women undergo three to six days of injections, as opposed to between eight and 11 days with IVF. After the eggs are retrieved, they are matured in a lab for three days and then implanted. The shorter IVM process could be helpful for women who are undergoing chemotherapy, radiation, or have plans to have surgery, as well as those who are sensitive to a form of estrogen known as estradiol, which elevates during the processes. It’s also cheaper, because there are fewer hormones required.
IVM implant success rates have proven to be between 5.5 and 21.6 percent. The journal Facts, Views and Vision found that IVM had comparable success rates to IVF for young women – 35 percent – but there are no studies that compare IVM and IVF side by side. Because IVM still is in the experimental phase, there is no research on the outcomes of birth defects or developmental delays.
Read the full story at Fox Health.